Tag MISHA C. HAWKINS

Process and General Management of Patients Undergoing Chimeric Antigen Receptor Therapies

Introduction The introduction of chimeric antigen receptor (CAR) T-cell therapies represents the culmination of a decades-long journey to harness the immune system and exploit the antitumoral potential of immune cells to treat cancer. The first clinical experiences describing the administration…